Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin

Heidenreich, 2011, Guía de la EAU sobre el cancer de prostata. Parte I: cribado diagnóstico y tratamiento del cáncer clínicamente localizado, Actas Urol Esp, 35, 501 Cózar, 2013, National prostate cancer registry 2010 in Spain, Actas Urol Esp, 37, 12, 10.1016/j.acuro.2012.06.006 Eichler, 2006, Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review, J Urol, 175, 1605, 10.1016/S0022-5347(05)00957-2 Loeb, 2013, Systematic review of complications of prostate biopsy, Eur Urol, 64, 876, 10.1016/j.eururo.2013.05.049 Muñoz, 2009, Antibiotic prophylaxis in transrectal prostate biopsy, Actas Urol Esp, 33, 853, 10.1016/S0210-4806(09)72871-2 Grabe, 2004, Controversies in antibiotic prophylaxis in urology, Int J Antimicrob Agents, 23, 17, 10.1016/j.ijantimicag.2003.09.005 Tal, 2003, Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy, J Urol, 169, 1762, 10.1097/01.ju.0000061280.23447.29 2013, 9 Loeb, 2012, Infectious complications and hospital admissions after prostate biopsy in a European randomized trial, Eur Urol, 61, 1110, 10.1016/j.eururo.2011.12.058 Zani, 2011, Antibiotic prophylaxis for transrectal prostate biopsy, Cochrane Database Syst Rev, 5, CD006576 Carignan, 2012, Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis, Eur Urol, 62, 453, 10.1016/j.eururo.2012.04.044 Schito, 2009, The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections, Int J Antimicrob Agents, 34, 407, 10.1016/j.ijantimicag.2009.04.012 Palou, 2011, Etiology and sensitivity of uropathogens identified in uncomplicated lower urinary tract infections in women (ARESC study): implications on empiric therapy, Med Clin (Barc), 136, 1, 10.1016/j.medcli.2010.02.042 Palou, 2013, Randomized comparative study for the assessment of a new therapeutic schedule of fosfomycin trometamol in postmenopausal women with uncomplicated lower urinary tract infection, Actas Urol Esp, 37, 147, 10.1016/j.acuro.2012.06.007 Bostwick, 2006, Prostate biopsy and optimization of cancer yield, Eur Urol, 49, 415, 10.1016/j.eururo.2005.12.052 Bosquet, 2006, Estudio comparativo entre tobramicina y tobramicina más ciprofloxacino como profilaxis para la biopsia transrectal de próstata, Acast Urol Esp, 30, 866, 10.1016/S0210-4806(06)73552-5 Otrock, 2004, Incidence of urinary tract infection following transrectal ultrasound guided prostate biopsy at a tertiary-care medical center in Lebanon, Infect Control Hosp Epidemiol, 25, 873, 10.1086/502312 Ho, 2009, Intramuscular gemtamicin improves the efficacy of ciprofloxacin as an antibiotic prophylaxis for transrectal prostate biopsy, Ann Acad Med Singapore, 38, 212, 10.47102/annals-acadmedsg.V38N3p212 Miura, 2008, Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature, Int J Urol, 15, 457, 10.1111/j.1442-2042.2007.01975.x Wagenlehner, 2013, Infective complications after prostate biopsy: Outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study, Eur Urol, 63, 521, 10.1016/j.eururo.2012.06.003 Nam, 2010, Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy, J Urol, 183, 963, 10.1016/j.juro.2009.11.043 Garau, 2001, Fosfomycin: an underrated antibiotic for urinary tract infections due to Escherichia coli, Enferm Infecc Microbiol Clin, 19, 462, 10.1016/S0213-005X(01)72702-4 Smyth, 2012, Antibiotic prophylaxis for transrectal ultrasound biopsy of the prostate in Ireland, Ir J Med Sci, 181, 33, 10.1007/s11845-011-0774-5 Fink, 2007, Prostate biopsy in Central Europe: results of a survey of indication, patient preparation and biopsy technique, Urol Int, 79, 60, 10.1159/000102916 Zaytoun, 2011, Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment, Urology, 77, 1035, 10.1016/j.urology.2010.12.067 Saenz, 2001, Antibiotic resistance in Escherichia coli isolates obtained from animals, foods and humans in Spain, Int J Antimicrob Agents, 67, 353, 10.1016/S0924-8579(01)00422-8 Siriboon, 2012, Prevalence of antibiotic resistance in fecal flora of patients undergoing transrectal ultrasound-guided prostate biopsy in Thailand, Urol Int, 88, 187, 10.1159/000335506 Binsaleh, 2004, Septic shock after transrectal ultrasound guided prostatic biopsy. Is ciprofloxacin prophylaxis always protecting?, Can J Urol, 11, 2352 Falagas, 2010, Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing enterobacteriaceae infections: a systematic review, Lancet Infect Dis, 10, 43, 10.1016/S1473-3099(09)70325-1 Taylor, 2013, Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy, BJU Int, 111, 946, 10.1111/j.1464-410X.2012.11637.x Ongün, 2012, The effectiveness of single-dose fosfomycin as antimicrobial prophylaxis for patients undergoing transrectal ultrasound-guided biopsy of the prostate, Urol Int, 89, 439, 10.1159/000342370 Davidson, 2006, Multi-resistant Escherichia coli sepsis followed transrectal ultrasound-guided prostate biopsy, Br J Hosp Med (Lond), 67, 98, 10.12968/hmed.2006.67.2.20472 Akduman, 2011, Long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms, Urology, 78, 250, 10.1016/j.urology.2011.02.065 Garg, 2013, Effectiveness of single-dose fosfomicin as antimicrobial prophylaxis in transrectal ultrasound-guided biopsy of the prostate, Urol Int, 91, 124, 10.1159/000350728 Raz, 2012, Foisfomycin: an old–new antibiotic, Clin Microbiol Infect, 18, 4, 10.1111/j.1469-0691.2011.03636.x Ishizaka, 2007, Randomized prospective comparison of fosfomycin and cefotiam for prevention of postoperative infection following urological surgery, J Infect Chemother, 13, 324, 10.1007/s10156-007-0544-5 Lee, 2008, The role of transrectal ultrasound and biopsy in the diagnosis and management of prostate cancer, Imaging, 20, 122, 10.1259/imaging/41490379 Lee, 2009, Risk factors associated with transrectal ultrasound guided prostate needle biopsy in patients with prostate cancer, Chang Gung Med J, 32, 623 Pinkhasov, 2012, Complications following prostate needle biopsy requiring hospital admission or emergency epartment visits—experience from 1,000 consecutive cases, BJU Int, 110, 369, 10.1111/j.1464-410X.2011.10926.x De Jesus, 2006, Complications and risk factors in transrectal ultrasound-guided prostate biopsies, Sao Paulo Med J, 124, 198, 10.1590/S1516-31802006000400005 Raaijmakers, 2002, Complication rates and risk factors of 5,802 transrectal ultrasound guided sextant biopsies of the prostate within a population-based screening program, Urology, 60, 826, 10.1016/S0090-4295(02)01958-1 Ecke, 2008, Complications and risk factors of transrectal ultrasound guided needle biopsies of the prostate evaluated by questionnaire, Urol Oncol, 26, 474, 10.1016/j.urolonc.2007.12.003